| [1] |
Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by The American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm-2019 Executive Summary[J]. Endocrine Practice, 2019, 25(1): 69-100.
|
| [2] |
陈春明, 孔灵芝, 中华人民共和国卫生部疾病控制司. 中国成人超重和肥胖症预防控制指南[M]. 北京: 人民卫生出版社, 2006.
|
| [3] |
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes:a joint statement by international diabetes organizations[J]. Diabetes Care, 2016, 39(6): 861-877.
|
| [4] |
Rao Wensheng, Shan Chengxiang, Zhang Wei, et al. A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI≤35 kg/m2 undergoing Roux-en-Y gastric bypass[J]. World Journal of Surgery, 2015, 39(1): 223-230.
|
| [5] |
Cummings DE, Cohen RV. Bariatric/Metabolic surgery to treat type 2 diabetes in patients with a BMI<35 kg/m2[J]. Diabetes Care, 2016, 39(6): 924-933.
|
| [6] |
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes[J]. The New England Journal of Medicine, 2017, 376(7): 641-651.
|
| [7] |
Lee MH, Lee WJ, Chong K, et al. Predictors of long-term diabetes remission after metabolic surgery[J]. Journal of Gastrointestinal Surgery: official journal of the Society for Surgery of the Alimentary Tract, 2015, 19(6): 1015-1021.
|
| [8] |
Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 years in the diabetes surgery study[J]. Jama, 2018, 319(3): 266-278.
|
| [9] |
Sjoholm K, Pajunen P, Jacobson P, et al. Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study[J]. Diabetologia, 2015, 58(7): 1448-1453.
|
| [10] |
Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial[J]. Lancet (London, England), 2018, 391(10120): 541-551.
|
| [11] |
王勇. 代谢外科临床研究的焦点问题以及发展方向[J].中国实用外科杂志, 2018, 38(02): 192-194.
|
| [12] |
Lebovitz HE. Metabolic surgery for type 2 diabetes with BMI<35 kg/m2: an endocrinologist's perspective[J]. Obesity Surgery, 2013, 23(6): 800-808.
|
| [13] |
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel[J]. Annals of internal medicine, 1991, 115(12): 956-961.
|
| [14] |
刘金钢,郑成竹, 等. 中国肥胖和2型糖尿病外科治疗指南(2014)[J]. 中国实用外科杂志, 2014, 34(11): 1005-1010.
|
| [15] |
王勇,王存川,朱晒红, 等. 中国肥胖及2型糖尿病外科治疗指南(2019版)[J].中国实用外科杂志, 2019, 39(04): 301-306.
|
| [16] |
Langenberg C, Sharp SJ, Schulze MB, et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study[J]. PLoS Medicine, 2012, 9(6): e1001230.
|
| [17] |
Muller MJ, Lagerpusch M, Enderle J,et al. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome[J]. Obesity Reviews, 2012, 13 ( Suppl 2): 6-13.
|
| [18] |
Thomas EL, Parkinson JR, Frost GS, et al. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat[J]. Obesity (Silver Spring, Md), 2012, 20(1): 76-87.
|
| [19] |
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial[J]. Lancet (London, England), 2015, 386(9997): 964-673.
|
| [20] |
Panunzi S, De Gaetano A, Carnicelli A,et al. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis[J]. Annals of Surgery, 2015, 261(3): 459-467.
|
| [21] |
Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications[J]. Jama, 2014, 311(22): 2297-2304.
|
| [22] |
Nguyen KT, Billington CJ, Vella A, et al. Preserved insulin secretory capacity and weight loss are the predominant predictors of glycemic control in patients with type 2 diabetes randomized to Roux-en-Y gastric bypass[J]. Diabetes, 2015, 64(9): 3104-3110.
|
| [23] |
Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery[J]. The Lancet Diabetes &Endocrinology, 2014, 2(2): 152-164.
|
| [24] |
Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease[J]. Annals of Surgery. 2004,239(1):1-11.
|
| [25] |
Zhu Jiangfan, Gupta R, Safwa M. The Mechanism of metabolic surgery: gastric center hypothesis[J]. Obesity Surgery, 2016, 26(7): 1639-1641.
|
| [26] |
朱江帆. 减肥手术治疗代谢综合征的机制:胃中心假说[J/CD].中华肥胖与代谢病电子杂志, 2015, 1(01): 39-40.
|
| [27] |
Baud G, Daoudi M, Hubert T, et al. Bile diversion in Roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake[J]. Cell Metabolism, 2016, 23(3): 547-553.
|
| [28] |
Rhee NA, Wahlgren CD, Pedersen J, et al. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes[J]. Diabetologia, 2015, 58(10): 2254-2258.
|
| [29] |
Zhong Mingwei, Liu Shaozhuang, Zhang Guangyong, et al. Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats[J]. World Journal of Gastroenterology, 2016, 22(29): 6706-6715.
|
| [30] |
Liu Ruixin, Hong Jie, Xu Xiaoqiang, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention[J]. Nature Medicine, 2017, 23(7): 859-868.
|
| [31] |
Garvey WT, Garber AJ, Mechanick JI, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease[J]. Endocrine practice, 2014, 20(9): 977-989.
|
| [32] |
Berry MA, Urrutia L, Lamoza P, et al. Sleeve gastrectomy outcomes in patients with BMI between 30 and 35-3 years of follow-up[J]. Obesity Surgery, 2018, 28(3): 649-655.
|
| [33] |
Liang Hui, Guan Wei, Yang Yanling, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI<28 kg/m2: a multi-institutional study[J]. Journal of Biomedical Research, 2015, 29(2): 112-117.
|
| [34] |
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery[J]. Obesity (Silver Spring, Md), 2013, 21 (Suppl 1):S1-27.
|
| [35] |
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes[J]. The New England Journal of Medicine. 2014, 370(21): 2002-2013.
|
| [36] |
吴安健,刘兢文,徐晓, 等. 多维度探讨代谢手术的合理选择[J/CD].中华肥胖与代谢病电子杂志, 2017, 3(03): 154-157.
|
| [37] |
Sepulveda M, Alamo M, Preiss Y, et al. Metabolic surgery comparing sleeve gastrectomy with jejunal bypass and Roux-en-Y gastric bypass in type 2 diabetic patients after 3 years[J]. Obesity Surgery, 2018, 28(11): 3466-3473.
|
| [38] |
Alamo M, Sepulveda M, Gellona J, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index<35 kg/m2[J]. A cohort study. Obesity Surgery, 2012, 22(7): 1097-1103.
|
| [39] |
董光龙,金露佳. 对腹腔镜胃袖状切除术的再思考[J].外科理论与实践, 2018, 23(06): 481-485.
|
| [40] |
刘婷,赖惠婷,郭夏娜, 等. 不同肥胖指标对糖尿病风险预测的效果观察[J]. 中医临床研究, 2018, 10(12): 61-62.
|
| [41] |
Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study[J]. The Lancet Diabetes & Endocrinology, 2014, 2(1): 38-45.
|
| [42] |
Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surgery Obesity Related Disease[J]. 2013, 9(3): 379-384.
|
| [43] |
Bruno G, Gruden G, Barutta F, et al. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients[J]. Surgery Obesity Related Disease, 2015, 11(5): 1014-1019.
|